Literature DB >> 6537095

Lysosomal gold accumulations in pulmonary macrophages.

P Pääkö, S Anttila, S Sutinen, M Hakala.   

Abstract

Although soluble gold has been widely used in the treatment of rheumatoid arthritis, little is known about the distribution of gold deposits in extra-articular tissues. In the synovial lining cells and articular cartilage, the morphology of lysosomes containing gold, the aurosomes, is well documented. Because gold may cause pulmonary injury, the morphology and distribution of gold deposits in pulmonary tissue should be recognized. We found morphologically typical aurosomes with electron-dense membranes and granules, giving the spectrum of gold in electron microprobe analysis, in the interstitial and alveolar macrophages in the open lung biopsies of 3 patients who had received gold treatment but not in 12 patients who had not received gold treatment. In contrast to previous studies, aurosomes were not found in the endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6537095     DOI: 10.3109/01913128409141489

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  3 in total

1.  Evaluation of the skin-sensitizing potential of gold nanoparticles and the impact of established dermal sensitivity on the pulmonary immune response to various forms of gold.

Authors:  K A Roach; S E Anderson; A B Stefaniak; H L Shane; G R Boyce; J R Roberts
Journal:  Nanotoxicology       Date:  2020-09-10       Impact factor: 5.913

2.  Heavy metals in the terrestrial isopod Porcellio scaber Latreille. II. Subcellular fractionation of metal-accumulating lysosomes from hepatopancreas.

Authors:  R Dallinger; F Prosi
Journal:  Cell Biol Toxicol       Date:  1988-03       Impact factor: 6.691

Review 3.  Prospecting Cellular Gold Nanoparticle Biomineralization as a Viable Alternative to Prefabricated Gold Nanoparticles.

Authors:  Aaron S Schwartz-Duval; Konstantin V Sokolov
Journal:  Adv Sci (Weinh)       Date:  2022-05-04       Impact factor: 17.521

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.